Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study
Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study
"La Casa nel Parco" (CANP) Project is a multidisciplinary project funded by the European
 Union and Regione Piemonte aimed to explore innovative technology application in the care of
 older subjects. In this context, MONTEROSA is a monocentric randomized controlled open-label
 clinical trial evaluating the use of a telemonitoring/telemedicine (TM) suite (including a
 sphygmomanometer, pulse oximeter, weight scale, thermometer, glucometer, electrocardiograph)
 as a support to the routine clinical care of patients admitted to a Hospital at Home service
 for acute decompensated heart failure.

 The main objective of the study will be to evaluate the impact of TM on number of daily
 physician's visits. Secondary objectives will be to evaluate the impact of TM on number of
 daily nurse visits, on overall in-hospital mortality and on patient's and caregiver's quality
 of life.
Inclusion Criteria:

 -  Patient admitted in Hospital at Home with signs and/or symptoms of new-onset or
 decompensated heart failure, according with the definition of 2016 European Society of
 Cardiology (ESC) guidelines on Heart Failure

 -  Written informed consent signed by both the patient and the main caregiver

 Exclusion Criteria:

 -  Main caregiver with low IT skills (e.g. unable to use a smartphone);

 -  Patient in whom body weight or accurate daily urine output cannot be measured

 -  Patient with history of neoplastic/degenerative disease and with estimated life
 expectancy less than 3 months

 -  Patient with decompensated liver cirrhosis (Child-Pugh score B o C)